Technical Analysis for BHC - Bausch Health Companies Inc.

Grade Last Price % Change Price Change
C 10.950 -1.88% -0.210
BHC closed down 1.88 percent on Friday, October 11, 2024, on approximately normal volume.
Earnings due: Oct 30
*** please verify all earnings dates ***
1 Watcher
Watchlist Portfolio

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Strong Up Up Down

Date Alert Name Type % Chg
20 DMA Support Bullish 0.00%
Inside Day Range Contraction 0.00%
Bullish Engulfing Bullish -1.88%
Wide Bands Range Expansion 0.46%
Down 3 Days in a Row Weakness 0.46%
MACD Bearish Signal Line Cross Bearish -0.73%
Wide Bands Range Expansion -0.73%
Overbought Stochastic Strength -0.73%
Slingshot Bullish Bullish Swing Setup -1.79%
Wide Bands Range Expansion -1.79%

   Recent Intraday Alerts

Alert Time
Possible Inside Day 2 days ago
20 DMA Support 2 days ago
Down 2% 2 days ago
Down 1% 2 days ago
Fell Below 10 DMA 2 days ago

Get a Trading Sidekick!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Bausch Health Companies Inc. Description

Bausch Health Companies Inc, formerly Valeant Pharmaceuticals International Inc, is a Canada-based company that develops, manufactures and markets a range of branded and generic pharmaceuticals, medical devices and over-the-counter products. It primarily develops products in the therapeutic areas of eye health, gastroenterology and dermatology. Its dermatology products treat a range of conditions, including actinic keratosis, acne, atopic dermatitis, psoriasis and other dermatoses. It also offers a selection of aesthetic medical devices that address a variety of conditions, including facial wrinkles, acne, pigmentation conditions and laser hair removal, among others. The gastrointestinal (GI) segment offers products that treat GI and hepatologic conditions, including hepatic encephalopathy, irritable bowel syndrome with diarrhea and ulcerative colitis, among others. Its eye health products are marketed in the following categories: Contact Lens, Pharmaceutical Products and Surgical.


Classification

Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Keywords: Health S&P/Tsx 60 Index Medicine Pharma Pharmaceutical Biotechnology Pharmaceuticals Pharmaceutical Products Laser Medical Devices Atopic Dermatitis Contact Lens Psoriasis Ulcer Ulcerative Colitis Aes Dermatology Specialty Drugs Acne Actinic Keratosis Colitis Hair Removal Irritable Bowel Syndrome Keratosis Over The Counter Products

Is BHC a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 15.43
52 Week Low 5.45
Average Volume 384,422
200-Day Moving Average 10.401
50-Day Moving Average 9.146
20-Day Moving Average 10.883
10-Day Moving Average 11.092
Average True Range 0.337
RSI (14) 62.55
ADX 40.61
+DI 32.348
-DI 15.517
Chandelier Exit (Long, 3 ATRs) 10.520
Chandelier Exit (Short, 3 ATRs) 9.520
Upper Bollinger Bands 11.762
Lower Bollinger Band 10.004
Percent B (%b) 0.54
BandWidth 16.154
MACD Line 0.534
MACD Signal Line 0.620
MACD Histogram -0.0855
Fundamentals Value
Market Cap 3.89 Billion
Num Shares 355 Million
EPS -2.61
Price-to-Earnings (P/E) Ratio -4.20
Price-to-Sales 0.84
Price-to-Book 11.59
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 11.370
Resistance 3 (R3) 11.393 11.277 11.300
Resistance 2 (R2) 11.277 11.170 11.265 11.277
Resistance 1 (R1) 11.113 11.104 11.055 11.090 11.253
Pivot Point 10.997 10.997 10.968 10.985 10.997
Support 1 (S1) 10.833 10.890 10.775 10.810 10.647
Support 2 (S2) 10.717 10.824 10.705 10.623
Support 3 (S3) 10.553 10.717 10.600
Support 4 (S4) 10.530